Should all healthy newborns get their DNA screened? study investigates

NCT ID NCT05161169

Completed Knowledge-focused Sponsor: Brigham and Women's Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether whole genome sequencing can help screen healthy babies for genetic health risks. Researchers enrolled 500 infants and their parents from three U.S. cities, took a small blood sample from each baby, and sequenced the DNA of half the group. After three months, they shared the results with families and doctors to study the medical, emotional, and financial effects of this approach.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENETIC PREDISPOSITION TO DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hereditary disease inherited disease susceptibility

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GENETIC PREDISPOSITION TO DISEASE HEREDITARY DISEASES

Contacts and locations

Locations

Beaumont - Corewell Health East

Royal Oak, Michigan, 48073, United States
Boston Children's Hospital

Boston, Massachusetts, 02115, United States
Icahn School of Medicine at Mount Sinai

New York, New York, 10029, United States
University of Alabama at Birmingham

Birmingham, Alabama, 35294, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.